MASI - Masimo Book Valuation of Business

MASI (masimo.com) - company brandmark

Masimo Corporation (MASI) maintains stable demand through clinic contracts, while the company actively integrates its developments into consumer gadgets. The brand's impeccable authority in non-invasive health monitoring is validated by the precision of its systems. Historical price action, where the value is 0.79, links these successes to a strong technological foundation. Ultra-precise sensors in intensive care units and automation software establish the Masimo Corporation (MASI) infrastructure as a global standard.

MASI Masimo Book Capitalization (07/04/2022 - 06/21/2026)

Masimo (MASI) - metric breakdowns and financial figures

- price and consensus price forecast:
Market Chart Masimo Inc.|MASI - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Masimo Corp|MASI - Total Company Value
- book capitalization data:
Accounting Value per Share Masimo|MASI - Book Capitalization|Market-to-Book Ratio masimo.com|MASI - Company Total Assets
- debt and liquidity data:
Debt to Equity Ratio Masimo Corporation|MASI - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Masimo Corp|MASI - Company Aggregate Debts|Debt to Book Value Masimo Corp
Fundamental valuation:MASI - Masimo Inc.
Mass-produced product of Masimo Personal Health

To identify fundamental support for Masimo Corporation (MASI), it is essential to evaluate the difference between total assets and all financial liabilities. By analyzing the company's equity, an investor determines the size of the internal reserve that protects proprietary monitoring technologies and long-term contracts amidst fierce competition, confirming the overall financial stability and solvency of the business.

Competitor analysis for Masimo Corporation

ISRG - Book Valuation of Business|Danaher Corp. - Book Capitalization|BDX (bd.com) - Book Valuation of Business|Company Book Value STE|Company Net Assets West Pharma|Baxter Corp - Book Capitalization|Total Stockholders' Equity Stevanato Group Corp (STVN)|TFX - Book Capitalization|Accounting Capitalization merit.com MMSI|Book Capitalization NVST (Envista)|ICUI - Book Valuation of Business|XRAY (Dentsply) - Book Capitalization|LeMaitre Corp (LMAT) - Company Net Assets|ATRC (AtriCure, Inc.) - Book Capitalization|Book Capitalization STAA|Company Book Value ChromaDex Corporation (NAGE)|Company Book Value ZimVie Inc ZIMV|Company Net Assets AngioDynamics Corp|Accounting Value of Company Cerus Inc CERS|Book Capitalization TKNO (Alpha Teknova, Inc.)|MGRM: Book Valuation of Business|Company Book Value sharpstechnology.com|INFU (InfuSystem Holdings, Inc.) - Accounting Capitalization|UTMD: Company Book Value|Book Valuation of Business KORU Medical Systems Inc. (KRMD)|Company Net Assets Nyxoah S.A.|Total Net Assets MBOT (microbotmedical.com)|Company Book Value Pro-Dex|ZTEK - Accounting Value of Company|Elutia Corp - Company Net Assets|MLSS: Book Capitalization|NXGL (NEXGEL, Inc.) - Company Book Value|Retractable Technologies, Inc. (RVP) - Company Net Assets|Book Capitalization HBIO (Harvard Bioscience, Inc.)|Total Stockholders' Equity FEMY|Company Book Value MeihuaMed MHUA|Accounting Capitalization predictive-oncology.com POAI|Company Net Assets Callan JMB (CJMB)|atrioncorp.com - Total Net Assets|Company Book Value NURO (NeuroMetrix)